Patterns of Efficacy, Toxicity and Treatment Discontinuation in HCC Patients Receiving Capecitabine Monotherapy von Abdel-Rahman, O.M., Abdelwahab, M.M., Shaker, M.K., Abdelwahab, S.A., Elbassiony, M.M., Ellithy, M.M.

Volltext

Does the Use of Sorafenib for Advanced Hcc Follow Appropriate Selection Criteria? von Abdel-Rahman, O.M., Abdelwahab, M.M., Shaker, M.K., Abdelwahab, S.A., Elbassiony, M.M., Ellithy, M.M.

Volltext